Clinical biomarkers differentiate myelitis from vascular and other causes of myelopathy

Abstract

This study provides Class IV evidence that for patients presenting with myelopathy, temporal profile of symptoms, initial motor examination, and MRI lesion distribution distinguish those with inflammatory myelopathies from those with other causes of myelopathy.